US Stock MarketDetailed Quotes

BDX Becton Dickinson & Co

Watchlist
  • 247.785
  • +1.255+0.51%
Trading Mar 28 13:52 ET
71.59BMarket Cap59.00P/E (TTM)

About Becton Dickinson & Co Company

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Company Profile

SymbolBDX
Company NameBecton Dickinson & Co
Listing Date05/16/1962
Issue Price25.00
Founded1897
CEOMr. Thomas E. Polen, Jr
MarketNYSE
Employees72000
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address1 Becton Drive
CityFranklin Lakes
ProvinceNew Jersey
CountryUnited States of America
Zip Code07417-1880
Phone1-201-847-6800

Company Executives

  • Name
  • Position
  • Salary
  • Thomas E. Polen, Jr
  • Chairman of the Board, Chief Executive Officer and President
  • 17.31M
  • Shana Carol Neal
  • Executive Vice President and Chief People Officer
  • 5.89M
  • Thomas Spoerel
  • Senior Vice President, Controller, Chief Accounting Officer and International Chief Financial Officer
  • --
  • Antoine C. Ezell
  • Executive Vice President, President, North America and Chief Marketing Officer
  • --
  • Christopher DelOrefice
  • Executive Vice President and Chief Financial Officer
  • 5.21M
  • David Shan
  • Executive Vice President and Chief Integrated Supply Chain Officer
  • --
  • Gary M. DeFazio
  • Senior Vice President and Corporate Secretary
  • --
  • Patrick Kaltenbach
  • Executive Vice President and President, Life Sciences Segment
  • 5.23M
  • Roland Goette
  • Executive Vice President and President, EMEA
  • --
  • David Hickey
  • Executive Vice President and President, Life Sciences Segment
  • 3.35M
  • Pavan Kumar Mocherla
  • Executive Vice President and President, Greater Asia
  • --
  • Michael Garrison
  • Executive Vice President and President, Medical Segment
  • 3.65M
  • Richard Byrd
  • Executive Vice President and President, Interventional Segment
  • --
  • Michelle Quinn
  • Executive Vice President and General Counsel
  • --
  • Bertram L. Scott
  • Lead Independent Director
  • 372.78K
  • Catherine M. Burzik
  • Independent Director
  • 357.78K
  • Dr. Claire M. Fraser-Liggett,PhD
  • Independent Director
  • 347.58K
  • Timothy M. Ring
  • Independent Director
  • 332.78K
  • William M. Brown
  • Independent Director
  • 332.78K
  • Jeffrey W. Henderson
  • Independent Director
  • 357.78K
  • R. Andrew Eckert
  • Independent Director
  • 362.77K
  • Christopher Ian Montague Jones
  • Independent Director
  • 362.78K
  • Dr. Carrie L. Byington
  • Independent Director
  • 337.78K
  • Dr. Joanne Waldstreicher, M.D.
  • Independent Director
  • 119.92K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg